Text Size

Novel Biomarkers in Chronic Airway Diseases

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Chonbuk National University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Chonbuk National University
ClinicalTrials.gov Identifier:
NCT00849836
First received: February 23, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted
  Purpose

The purpose of this study is:

  • To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
  • To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.

Condition
Asthma
COPD

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Study for The Identification of Novel Biomarkers in Chronic Airway Inflammatory Disorders

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Chonbuk National University:

Estimated Enrollment: 30
Study Start Date: February 2009
Estimated Study Completion Date: January 2010
Groups/Cohorts
Acute exacerbation
Stable disease
Healthy control

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients with acute exacerbation of asthma or COPD, patients with stable status of those disease, and the healthy control subjects

Criteria

Inclusion Criteria:

  • > 18 years olds
  • Both sexes
  • Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
  • Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
  • For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00849836

Contacts
Contact: So Ri Kim, MD, PhD 82-63-250-2475 sori@chonbuk.ac.kr
Contact: Yong Chul Lee, MD, PhD 82-63-250-1664 leeyc@chonbuk.ac.kr

Locations
Korea, Republic of
Chonbuk National University Medical School Recruiting
Jeonju, Korea, Republic of, 561-180
Contact: So Ri Kim, MD, PhD         sori@chonbuk.ac.kr    
Contact: Yong Chul Lee, MD, PhD         leeyc@chonbuk.ac.kr    
Principal Investigator: Yong Chul Lee, MD, PhD            
Sub-Investigator: So Ri Kim, MD, PhD            
Sponsors and Collaborators
Chonbuk National University
  More Information

No publications provided

Responsible Party: Yong Chul Lee, Chonbuk National University Medical School
ClinicalTrials.gov Identifier: NCT00849836     History of Changes
Other Study ID Numbers: RCPD
Study First Received: February 23, 2009
Last Updated: February 23, 2009
Health Authority: Korea: Food and Drug Administration

Additional relevant MeSH terms:
Asthma
Pulmonary Disease, Chronic Obstructive
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
 Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on May 19, 2013